{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T14:05:41Z","timestamp":1781964341595,"version":"3.54.5"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Tonsillar Kaposi sarcoma (KS) is an extremely rare manifestation of KS, a neoplasm associated with human herpesvirus-8 and often linked to immunocompromised individuals. This study aims to analyze the outcomes and prognostic factors of tonsillar KS using data from the SEER (Surveillance, Epidemiology, and End Results) database, covering cases from 2000 to 2020. A total of 42 patients were identified, with the vast majority being male (97.6%) and a mean age of 40.1\u00a0years. Tumors were primarily localized (42.9%), and treatment modalities varied, with radiation therapy being the most common (38.1%), followed by chemotherapy (21.4%) and surgery (19.0%). Survival analysis showed that 21.4% of patients had died by the last follow-up, but the median survival time was not reached, indicating a relatively favorable prognosis. No statistically significant survival differences were observed based on treatment modality or other demographic factors, though there were trends towards worse outcomes for patients with regional disease and longer delays in treatment initiation. The study highlights the rarity of tonsillar KS, its demographic profile, and suggests a generally positive prognosis, although further research is needed to optimize treatment strategies for this rare form of KS.<\/jats:p>","DOI":"10.1097\/ms9.0000000000003294","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T03:00:19Z","timestamp":1745204419000},"page":"3102-3106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes and prognostic factors of tonsillar Kaposi sarcoma in the United States SEER Database"],"prefix":"10.1097","volume":"87","author":[{"given":"Akef","family":"Obeidat","sequence":"first","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6292-7683","authenticated-orcid":false,"given":"Tarek Ziad","family":"Arabi","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Rahman","family":"Elhassan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Surgery, National University - Sudan, Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Elhassan","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Alaswad","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belal Nedal","family":"Sabbah","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"R1-20251204","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5858\/arpa.2012-0101-RS","article-title":"Kaposi sarcoma","volume":"137","author":"Radu","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R2-20251204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","article-title":"Kaposi Sarcoma","volume":"5","author":"Cesarman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20251204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.oraloncology.2009.12.006","article-title":"Kaposi\u2019s sarcoma of the head and neck: a review","volume":"46","author":"Ram\u00edrez-Amador","year":"2010","journal-title":"Oral Oncol"},{"key":"R4-20251204","first-page":"e57131","article-title":"Kaposi sarcoma mimicking a lingual lesion in an HIV-negative patient: a case report","volume":"16","author":"Andrade-Carmona","year":"2024","journal-title":"Cureus"},{"key":"R5-20251204","first-page":"437","article-title":"Tonsillar Kaposi\u2019s sarcoma in HIV positive patient with syphilis infection","volume":"36","author":"Lorusso","year":"2024","journal-title":"Iran J Otorhinolaryngol"},{"key":"R6-20251204","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi\u2019s sarcoma and its associated herpesvirus","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R7-20251204","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0973-1482.80456","article-title":"Classic Kaposi\u2019s sarcoma in Arabs\u2013widening ethnic involvement","volume":"7","author":"Kumar","year":"2011","journal-title":"J Cancer Res Ther"},{"key":"R8-20251204","doi-asserted-by":"crossref","first-page":"i43","DOI":"10.1093\/bjd\/ljae090.090","article-title":"P063 Understanding the landscape of Kaposi sarcoma hospitalizations in the USA: demographic associations stratified by AIDS\/HIV status","volume":"191","author":"Mendoza","year":"2024","journal-title":"Br J Dermatol"},{"key":"R9-20251204","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4103\/0976-9668.160041","article-title":"Oral Kaposi\u2019s sarcoma: sole presentation in HIV seropositive patient","volume":"6","author":"Arul","year":"2015","journal-title":"J Nat Sci Biol Med"},{"key":"R10-20251204","doi-asserted-by":"crossref","first-page":"970","DOI":"10.12688\/f1000research.17401.1","article-title":"Recent advances in HIV-associated Kaposi sarcoma","volume":"8","author":"Dalla Pria","year":"2019","journal-title":"F1000Res"},{"key":"R11-20251204","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/cancers14081915","article-title":"On behalf of Cancervih Working Group. The role of radiotherapy in treating Kaposi\u2019s Sarcoma in HIV infected patients","volume":"14","author":"Qu\u00e9ro","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R12-20251204","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13027-019-0242-9","article-title":"Three year survival among patients with aids-related Kaposi sarcoma treated with chemotherapy and combination antiretroviral therapy at Moi teaching and referral hospital, Kenya","volume":"14","author":"Busakhala","year":"2019","journal-title":"Infect Agent Cancer"},{"key":"R13-20251204","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/bjc.1996.635","article-title":"Survival of classic Kaposi\u2019s sarcoma and risk of second cancer","volume":"74","author":"Franceschi","year":"1996","journal-title":"Br J Cancer"},{"key":"R14-20251204","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi\u2019s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS clinical trials group oncology committee","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"R15-20251204","doi-asserted-by":"crossref","first-page":"171","DOI":"10.6004\/jnccn.2019.0008","article-title":"Freedman-Cass, AIDS-related Kaposi sarcoma, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Reid","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"R16-20251204","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1038\/bjc.2015.48","article-title":"Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes?","volume":"112 Suppl 1","author":"Neal","year":"2015","journal-title":"Syst Rev Br J Cancer"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:06:00Z","timestamp":1764835560000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003294","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"2024-12-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}